NCT00861705
Clinical Trial Information
Trial Number: NCT00861705 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
Study ID:
CALGB-40603
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00861705-D2 | The NCT00861705-D2-Dataset.csv (treated2) dataset is one of 2 datasets associated with PubMed ID 25092775. This dataset contains various information, including treatment information, patient characteristics, and tumor characteristics. There is one record for each treated patient (N=443). |
| NCT00861705-D1 | The NCT00861705-D1-Dataset.csv (aeclean) dataset is one of 2 datasets associated with PubMed ID 25092775. This dataset contains adverse event data for each treated patient (N=443). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®